Suchergebnisse - "Drayman, Nir"

PubPharm (59)

1

Shared sequence characteristics identified in non-canonical rearrangements of HSV-1 genomes

enthalten in: Journal of virology | 2023

von Shitrit, A. | Nisnevich, V. | Rozenshtein, N. | +7

2

Herpesviruses mimic zygotic genome activation to promote viral replication

enthalten in: Research square | 2023

von Full, F. | Walter, S. | Neugebauer, E. | +8

3

Herpesviruses mimic zygotic genome activation to promote viral replication

enthalten in: ResearchSquare.com | 2023

von Full, F. | Walter, S. | Neugebauer, E. | +8

4

Dissecting viral infections, one cell at a time, by single-cell technologies

enthalten in: Microbes and infection | 2023

von Bost, P. | Drayman, N.

5

mSphere of Influence : Virology in the noise-how cell-to-cell variability impacts viral infection outcomes

enthalten in: mSphere | 2023

von Drayman, N.

CommentOn: J Virol. 2015 Nov;89(21):11107-15. - PMID 26311877

6

Pharmaceuticals for Treating or Preventing Nidoviruses and Picornaviruses

enthalten in: Europäisches Patentamt | 2023

von TAY SAVAS | RANDALL GLENN | DRAYMAN NIR | +1

7

Pharmaceuticals for Treating or Preventing Nidoviruses and Picornaviruses

enthalten in: Europäisches Patentamt | 2023

von TAY SAVAS | RANDALL GLENN | DRAYMAN NIR | +1

8

HSV-1 single cell analysis reveals anti-viral and developmental programs activation in distinct sub-populations

enthalten in: bioRxiv.org | 2023

von Drayman, N. | Patel, P. | Vistain, L. | +1

9

USE OF MASITINIB FOR THE TREATMENT OF CORONAVIRUS DISEASE 2019 (COVID-19)

enthalten in: Europäisches Patentamt | 2023

von MOUSSY ALAIN | TAY SAVAS | DRAYMAN NIR | +2

10

USE OF MASITINIB FOR THE TREATMENT OF CORONAVIRUS DISEASE 2019 (COVID-19)

enthalten in: Europäisches Patentamt | 2023

von MOUSSY ALAIN | TAY SAVAS | DRAYMAN NIR | +2

1
2
3
4
5
6
Nächster »
[6]